<div id="readability-page-1"><div><div><p>Merck and Siemens have signed a new partnership to accelerate AI for drug development</p><p>Projects include the development of AI-based tools and digital interfaces to simplify complex scientific processes</p><p>The agreement covers the provision of integrated software solutions, systems, and consumables that leverage automation, data, and AI to connect discovery, development, and commercialization of drugs.</p><p>Through this collaboration with Siemens, we are opening up new possibilities for scientists to move more quickly from an idea in the lab to a treatment for patients, Marck said. </p><p>We are partnering with Merck to provide scientists around the world with the tools they need to accelerate the development of vital medicines, Siemens said.</p></div></div></div>

SIEGY

<p>Siemens and Merck have formed a partnership to enhance AI in drug development. The collaboration aims to create AI-based tools and digital interfaces to streamline scientific processes. The agreement includes integrated software solutions and systems that utilize automation and data to connect drug discovery, development, and commercialization. This partnership is expected to help scientists expedite the transition from lab ideas to patient treatments.</p>

Siemens accelerates drug discovery and development with Merck